M3bio Consulting: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
M3bio Consulting
Largest movements
- Cash -€156,531
down €156,531 (-52.5%), from €297,951 to €141,421
mainly Contributions, distributions and other (-€212,808) and Other debts (-€198,455)
- Current investments -€150,000
no longer reported in 2025 (was €150,000)
- Deferred charges and accrued income +€21,109
up €21,109 (+569%), from €3,707 to €24,816
- Tangible fixed assets +€6,741
up €6,741 (+22.0%), from €30,640 to €37,381
of which Furniture and vehicles: +€6,797
- Other debts -€198,455
down €198,455 (-47.9%), from €413,960 to €215,505
- Reserves -€76,052
no longer reported in 2025 (was €76,052)
- Trade debts +€5,723
up €5,723 (+594%), from €963 to €6,685
- Tax, wage and social debts -€5,469
down €5,469 (-49.5%), from €11,051 to €5,582
- Gross operating margin -€46,691
down €46,691 (-20.5%), from €227,260 to €180,569
- Taxes -€12,435
down €12,435 (-23.6%), from €52,788 to €40,353
- Financial income +€2,406
up €2,406 (+264%), from €912 to €3,318
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €504,292 | €229,772 | -€274,520 | -54.4% |
| Fixed assets | 21/28 | €30,640 | €37,381 | +€6,741 | +22.0% |
| Tangible fixed assets | 22/27 | €30,640 | €37,381 | +€6,741 | +22.0% |
| Plant, machinery and equipment | 23 | €3,587 | €3,221 | -€366 | -10.2% |
| Furniture and vehicles | 24 | €3,105 | €9,902 | +€6,797 | +219% |
| Other tangible fixed assets | 26 | €23,949 | €24,258 | +€309 | +1.3% |
| Current assets | 29/58 | €473,651 | €192,391 | -€281,260 | -59.4% |
| Amounts receivable within one year | 40/41 | €21,993 | €26,154 | +€4,161 | +18.9% |
| Trade receivables | 40 | €21,993 | €23,013 | +€1,020 | +4.6% |
| Other amounts receivable | 41 | - | €3,141 | +€3,141 | |
| Current investments | 50/53 | €150,000 | - | -€150,000 | |
| Cash at bank and in hand | 54/58 | €297,951 | €141,421 | -€156,531 | -52.5% |
| Deferred charges and accrued income | 490/1 | €3,707 | €24,816 | +€21,109 | +569% |
| Total equity and liabilities | 10/49 | €504,292 | €229,772 | -€274,520 | -54.4% |
| Equity | 10/15 | €78,052 | €2,000 | -€76,052 | -97.4% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €76,052 | - | -€76,052 | |
| Distributable reserves | 133 | €76,052 | - | -€76,052 | |
| Amounts payable | 17/49 | €426,239 | €227,772 | -€198,467 | -46.6% |
| Amounts payable within one year | 42/48 | €425,974 | €227,772 | -€198,202 | -46.5% |
| Trade debts | 44 | €963 | €6,685 | +€5,723 | +594% |
| Suppliers | 440/4 | €963 | €6,685 | +€5,723 | +594% |
| Taxes, remuneration and social security | 45 | €11,051 | €5,582 | -€5,469 | -49.5% |
| Taxes | 450/3 | €11,051 | €5,582 | -€5,469 | -49.5% |
| Other amounts payable | 47/48 | €413,960 | €215,505 | -€198,455 | -47.9% |
| Accrued charges and deferred income | 492/3 | €265 | - | -€265 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €4,371 | €4,919 | +€549 | +12.6% |
| Other operating charges | 640/8 | €686 | €302 | -€384 | -56.0% |
| Gross operating margin | 9900 | €227,260 | €180,569 | -€46,691 | -20.5% |
| Operating profit (loss) | 9901 | €222,203 | €175,348 | -€46,855 | -21.1% |
| Financial income | 75/76B | €912 | €3,318 | +€2,406 | +264% |
| Recurring financial income | 75 | €912 | €3,318 | +€2,406 | +264% |
| Financial charges | 65/66B | €401 | €1,557 | +€1,156 | +289% |
| Recurring financial charges | 65 | €401 | €1,557 | +€1,156 | +289% |
| Profit (loss) for the period before taxes | 9903 | €222,714 | €177,109 | -€45,605 | -20.5% |
| Income taxes | 67/77 | €52,788 | €40,353 | -€12,435 | -23.6% |
| Profit (loss) for the period | 9904 | €169,926 | €136,756 | -€33,170 | -19.5% |
| Profit (loss) for the period to be appropriated | 9905 | €169,926 | €136,756 | -€33,170 | -19.5% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.